These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 3791069)

  • 1. In vitro 31P NMR spectroscopy detects altered phospholipid metabolism in Alzheimer's disease.
    Miatto O; Gonzalez RG; Buonanno F; Growdon JH
    Can J Neurol Sci; 1986 Nov; 13(4 Suppl):535-9. PubMed ID: 3791069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered brain high-energy phosphate metabolism in mild Alzheimer's disease: A 3-dimensional
    Rijpma A; van der Graaf M; Meulenbroek O; Olde Rikkert MGM; Heerschap A
    Neuroimage Clin; 2018; 18():254-261. PubMed ID: 29876246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo 31P NMR profiles of Alzheimer's disease and multiple subcortical infarct dementia.
    Brown GG; Levine SR; Gorell JM; Pettegrew JW; Gdowski JW; Bueri JA; Helpern JA; Welch KM
    Neurology; 1989 Nov; 39(11):1423-7. PubMed ID: 2812317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative in vivo 31P magnetic resonance spectroscopy of Alzheimer disease.
    Gonzalez RG; Guimaraes AR; Moore GJ; Crawley A; Cupples LA; Growdon JH
    Alzheimer Dis Assoc Disord; 1996; 10(1):46-52. PubMed ID: 8919496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 31P nuclear magnetic resonance study of the brain in Alzheimer's disease.
    Pettegrew JW; Moossy J; Withers G; McKeag D; Panchalingam K
    J Neuropathol Exp Neurol; 1988 May; 47(3):235-48. PubMed ID: 3367156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of in vivo and in vitro 31P NMR spectra from human breast tumours: variations in phospholipid metabolism.
    Smith TA; Glaholm J; Leach MO; Machin L; Collins DJ; Payne GS; McCready VR
    Br J Cancer; 1991 Apr; 63(4):514-6. PubMed ID: 2021535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 31P magnetic resonance spectroscopy studies in schizophrenia.
    Williamson PC; Brauer M; Leonard S; Thompson T; Drost D
    Prostaglandins Leukot Essent Fatty Acids; 1996 Aug; 55(1-2):115-8. PubMed ID: 8888133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced phospholipid breakdown in Alzheimer's brains: a 31P spectroscopy study.
    Forlenza OV; Wacker P; Nunes PV; Yacubian J; Castro CC; Otaduy MC; Gattaz WF
    Psychopharmacology (Berl); 2005 Jul; 180(2):359-65. PubMed ID: 15700180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic alterations in postmortem Alzheimer's disease brain are exaggerated by Apo-E4.
    Klunk WE; Panchalingam K; McClure RJ; Stanley JA; Pettegrew JW
    Neurobiol Aging; 1998; 19(6):511-5. PubMed ID: 10192209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phospholipid abnormalities in early Alzheimer's disease. In vivo phosphorus 31 magnetic resonance spectroscopy.
    Cuénod CA; Kaplan DB; Michot JL; Jehenson P; Leroy-Willig A; Forette F; Syrota A; Boller F
    Arch Neurol; 1995 Jan; 52(1):89-94. PubMed ID: 7826281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative 1H and 31P MRS of PCA extracts of postmortem Alzheimer's disease brain.
    Klunk WE; Xu C; Panchalingam K; McClure RJ; Pettegrew JW
    Neurobiol Aging; 1996; 17(3):349-57. PubMed ID: 8725895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The medical food Souvenaid affects brain phospholipid metabolism in mild Alzheimer's disease: results from a randomized controlled trial.
    Rijpma A; van der Graaf M; Lansbergen MM; Meulenbroek O; Cetinyurek-Yavuz A; Sijben JW; Heerschap A; Olde Rikkert MGM
    Alzheimers Res Ther; 2017 Jul; 9(1):51. PubMed ID: 28747210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A human in vivo study of the extent to which 31-phosphorus neurospectroscopy phosphomonoesters index cerebral cell membrane phospholipid anabolism.
    Puri BK; Treasaden IH
    Prostaglandins Leukot Essent Fatty Acids; 2009; 81(5-6):307-8. PubMed ID: 19906517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnetic resonance spectroscopic changes in Alzheimer's disease.
    Pettegrew JW; Klunk WE; Panchalingam K; McClure RJ; Stanley JA
    Ann N Y Acad Sci; 1997 Sep; 826():282-306. PubMed ID: 9329700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of phosphorus-31 magnetic resonance spectroscopy and morphologic findings in Alzheimer's disease.
    Pettegrew JW; Panchalingam K; Moossy J; Martinez J; Rao G; Boller F
    Arch Neurol; 1988 Oct; 45(10):1093-6. PubMed ID: 3178529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered phospholipid metabolism in schizophrenia: a phosphorus 31 nuclear magnetic resonance spectroscopy study.
    Weber-Fahr W; Englisch S; Esser A; Tunc-Skarka N; Meyer-Lindenberg A; Ende G; Zink M
    Psychiatry Res; 2013 Dec; 214(3):365-73. PubMed ID: 24045051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 31P nuclear magnetic resonance (NMR) spectroscopy of brain in aging and Alzheimer's disease.
    Pettegrew JW; Withers G; Panchalingam K; Post JF
    J Neural Transm Suppl; 1987; 24():261-8. PubMed ID: 3316499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnetic resonance spectroscopy and its application to aging and Alzheimer's disease.
    McClure RJ; Kanfer JN; Panchalingam K; Klunk WE; Pettegrew JW
    Neuroimaging Clin N Am; 1995 Feb; 5(1):69-86. PubMed ID: 7743086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 31P NMR spectroscopy of phospholipid metabolites in postmortem schizophrenic brain.
    Komoroski RA; Pearce JM; Mrak RE
    Magn Reson Med; 2008 Mar; 59(3):469-74. PubMed ID: 18306399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proton and 31-phosphorus neurospectroscopy in the study of membrane phospholipids and fatty acid intervention in schizophrenia, depression, chronic fatigue syndrome (myalgic encephalomyelitis) and dyslexia.
    Puri BK
    Int Rev Psychiatry; 2006 Apr; 18(2):145-7. PubMed ID: 16777668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.